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Nardilysin regulates inflammation, 
metaplasia, and tumors in murine 
stomach
Yuto Kimura1, Kozo Ikuta1, Takeshi Kimura2, Tsutomu Chiba1, Hiroko Oshima3, 
Masanobu Oshima3, Eiichiro Nishi2 & Hiroshi Seno1
Chronic inflammation contributes to a wide variety of human disorders. In the stomach, longstanding 
gastritis often results in structural alterations in the gastric mucosa, including metaplastic changes and 
gastric cancers. Therefore, it is important to elucidate factors that are involved in gastric inflammation. 
Nardilysin (N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that 
promotes ectodomain shedding of the precursor forms of various growth factors and cytokines by 
enhancing the protease activities of a disintegrin and metalloproteinase (ADAM) proteins. Here, we 
have demonstrated that Nrdc crucially regulates gastric inflammation caused by Helicobacter felis 
infection or forced expression of prostaglandin E2 in K19-C2mE mice. Metaplastic changes following 
gastric inflammation were suppressed by the deletion of Nrdc. Furthremore, the deletion of Nrdc 
significantly suppressed N-methyl-N-nitrosourea (MNU)-induced gastric tumorigenesis in the murine 
stomach. These data may lead to a global therapeutic approach against various gastric disorders by 
targeting Nrdc.
Chronic inflammation contributes to a wide variety of human disorders. In the stomach, most lifelong 
chronic gastritis is caused by Helicobacter pylori infection1, although other etiologies, such as non-steroidal 
anti-inflammatory drugs or autoimmunity, are also prevalent2. Longstanding gastritis can result in structural 
alterations in the gastric mucosa, including metaplastic changes and gastric cancers. Metaplastic changes in the 
stomach are associated with an increased risk of gastric cancer3. Therefore, it is important to elucidate factors that 
are involved in gastric inflammation for effective prevention of various gastric diseases, including gastric cancer4.
The local microenvironment influences the development of chronic gastritis and metaplastic changes regard-
less of causative factors, and inflammatory cytokines participate in constructing this environment. There are a 
number of factors regulating inflammatory cytokines. A disintegrin and metalloproteinase (ADAM) family pro-
teins are involved in ectodomain shedding, and regulate the biological activities of structurally and functionally 
diverse inflammatory cytokines in a context-dependent manner5,6. Indeed, dysregulation of ectodomain shedding 
of those factors can be profoundly involved in the pathogenesis of a serial development of gastritis, metaplasia, 
and gastric cancer7.
Nardilysin (N-arginine dibasic convertase; NRDC), a zinc peptidase of the M16 family that selectively cleaves 
dibasic sites8, is diffusely localized in the cytoplasm, and is secreted to the cell surface by undetermined mech-
anisms9. We previously identified NRDC as a specific binding partner of heparin-binding epidermal growth 
factor-like growth factor (HB-EGF)10. NRDC also enhances the shedding of tumor necrosis factor-α (TNF-α) 
through activation of ADAM1711,12. TNF-α is produced as a membrane-anchored protein, shed from the cell sur-
face by proteolytic cleavage, and subsequently activated. The proinflammatory genotype of TNF-α is associated 
with more than twice the risk of non-cardia gastric cancer13. In this respect, we previously demonstrated that 
NRDC regulates activation of TNF-α and subsequent production of inflammatory cytokines in gastric cancer 
cells14. These findings suggest that NRDC regulates chronic inflammation and tumorigenesis in the stomach; 
however, the in vivo role of NRDC in the stomach is still unclear.
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In this study, we examined the role of Nrdc during the development of chronic gastritis and metaplastic 
changes in the stomach using Nrdc knockout mice. We also investigated the effect of Nrdc in chemically-induced 
gastric tumorigenesis.
Results
Nrdc did not alter the differentiation status of gastric mucosa under physiological conditions. 
We first examined the effects of Nrdc deletion in the stomach under physiological conditions. Nrdc−/− mice tend 
to maintain lower body weights than Nrdc+/+ mice15. Therefore, the mean stomach size of Nrdc−/− mice was 
slightly smaller than that of Nrdc+/+ mice (Fig. 1A). Other than the stomach size, there were no macroscopic 
differences between Nrdc+/+ and Nrdc−/− mice. Although the gastric mucosa was slightly thinner in Nrdc−/− mice 
Figure 1. Stomachs of Nrdc+/+ and Nrdc−/− mice under physiological conditions. (A) Representative 
macroscopic views of the stomachs of Nrdc+/+ and Nrdc−/− mice. (B) H&E staining of Nrdc+/+ and Nrdc−/− 
mouse stomachs. Bars = 100 μm. (C) Immunohistochemistry for pepsinogen II, H+/K+-ATPase, Muc5ac, TFF2, 
and Ki67 in Nrdc+/+ and Nrdc−/− mice. Bars = 100 μm. (D) Percentages of epithelial cells immunostained with 
pepsinogen II, H+/K+-ATPase, Muc5ac, TFF2, and Ki67 in Nrdc+/+ and Nrdc−/− mice.
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(Fig. 1B), there were no significant differences in the differentiation status of gastric mucosal cells (Fig. 1C). 
Immunohistochemistry showed that the percentages of pepsinogen II-positive cells within gastric glands were 
not significantly different between Nrdc+/+ and Nrdc−/− mice. This indicated that chief cell differentiation was not 
affected by Nrdc status (Fig. 1C and D). Further, immunostainings for H+/K+-ATPase, Muc5ac, and TFF2 did 
not show significant differences between Nrdc+/+ and Nrdc−/− mice, indicating that differentiation of parietal, 
pit, and mucous neck cells was not regulated by Nrdc under physiological conditions, respectively (Fig. 1C and 
D). Furthermore, the proportion of Ki67-positive cells in the gastric glands of Nrdc−/− mice was similar to that of 
Nrdc+/+ mice. Therefore, deletion of Nrdc did not alter epithelial cell proliferation under physiological conditions 
(Fig. 1C and D).
Gastritis caused by Helicobacter felis infection was attenuated by Nrdc deletion. Helicobacter 
felis infection is a well-characterized mouse model that mimics chronic Helicobacter pylori infection in the 
human stomach16. Based on a previous report16, we administered suspending water containing Helicobacter 
felis to Nrdc+/+ and Nrdc−/− mice for three days. Mice were sacrificed 20 weeks after the end of administration. 
Regardless of Nrdc gene status, Helicobacter felis was infected successfully into the gastric mucosae (Fig. 2A and B). 
The thickness of the mucosa of gastric corpus in Nrdc+/+ mice with Helicobacter felis infection was significantly 
different from mice without the infection, but was not significantly different from Nrdc−/− mice regardless of 
Helicobacter felis infection (Fig. 2C). Of note, formation of lymphoid follicles, a characteristic of Helicobacter 
felis infection, was scarce in Nrdc−/− mice (Fig. 2D), and the inflammation score was more severe in Nrdc+/+ 
than in Nrdc−/− mice with Helicobacter felis infection (Fig. 2E). Consistent with these findings, infiltration of 
Gr1-positive neutrophils was not prominent in Nrdc−/− mice, and that of F4/80-positive macrophages was signifi-
cantly decreased compared to Nrdc+/+ mice (Fig. 2F and G). The mRNA expression of Cxcl1 and Ccl2, factors that 
recruit neutrophils and macrophages, respectively, was also decreased in Nrdc−/− mice (Fig. 2H). Notably, mRNA 
levels of interleukin (IL)-1α, IL-1β, IL-6, and IL-12, that can contribute to chronic gastritis in humans13–17, were 
not significantly increased in Nrdc−/− mice (Fig. 2I). Thus, the deletion of Nrdc attenuates gastric inflammation 
caused by Helicobacter infection.
Gastritis caused by forced expression of prostaglandin (PG)E2 was attenuated by Nrdc deletion. 
We examined the role of Nrdc in K19-C2mE mice, another mouse model that expresses PGE2 abundantly in 
the gastric mucosa and mimics human gastritis16. Similar to Helicobacter felis–induced gastritis, mucosae of 
the gastric corpus of Nrdc+/+ mice were macroscopically thicker compared to Nrdc−/− mice at 30 weeks of age 
(Fig. 3A). Histologically, the mucosae of gastric corpus were remarkably hyperplastic in Nrdc+/+ mice, consist-
ent with a previous report16. However, this hyperplastic change was not prominent in Nrdc−/− mice (Fig. 3B). 
Consequently, mucosae were significantly thinner in Nrdc−/− mice (Fig. 3C). Infiltration of Gr1-positive neu-
trophils and F4/80-positive macrophages was significantly decreased in Nrdc−/− mice compared to Nrdc+/+ mice 
(Fig. 3D and E). The expression of Cxcl1 and IL-1β mRNA was significantly decreased in Nrdc−/− mice compared 
to Nrdc+/+ mice (Fig. 3F), although we could not demonstrate alterations of Ccl2, IL-1α, IL-6, and IL-12 mRNA 
between Nrdc+/+ and Nrdc−/− mice in the presence of K19-C2mE alleles. Thus, like Helicobacter felis–induced gas-
tritis, deletion of Nrdc attenuates gastric inflammation and hyperplasty caused by the forced expression of PGE2.
Metaplastic changes were attenuated by Nrdc deletion. We next investigated whether Nrdc plays 
a role in metaplastic changes following gastritis. Staining for TFF2 and/or staining with Alcian blue are widely 
used to detect metaplastic changes in the gastric corpus18. Upon Helicobacter felis infection for 20 weeks, the per-
centage of TFF2-stained cells was significantly lower in Nrdc−/− mice than in Nrdc+/+ mice (Fig. 4A and B). The 
percentage of Alcian blue-stained cells was also reduced in Nrdc−/− mice compared to Nrdc+/+ mice at 26 weeks 
of Helicobacter felis infection (Fig. 4C and D).
In K19-C2mE mice at the age of 30 weeks, Alcian blue staining showed that the development of metaplastic 
changes was significantly less prominent in Nrdc−/− mice compared with Nrdc+/+ mice (Fig. 4E and F). Together, 
these data indicate that the deletion of Nrdc leads to the suppression of metaplastic changes in the stomach.
Formation of gastric tumors was suppressed by Nrdc deletion. Chronic gastritis and metaplas-
tic changes are associated with the development of gastric cancers. In both Helicobacter felis infection and the 
K19-C2mE chronic gastritis mouse models, we noticed that the increase in the number of Ki67-positive cells 
in the gastric glands of Nrdc+/+ mice was not remarkable in Nrdc−/− mice (Fig. 5A). Based on this finding, we 
hypothesized that the formation of gastric tumors may also be suppressed in Nrdc−/− mice. Because it requires a 
long period to develop tumors in Helicobacter felis-infected mouse stomach, we administered a chemical carcino-
gen to rapidly induce mouse gastric tumors. Administration of N-methyl-N-nitrosourea (MNU) causes polypoid 
tumors in the gastric antrum with inflammatory reactions in the stroma19–21. In Nrdc+/+ mice, MNU treatment 
resulted in polyp formation in the gastric antrum (Fig. 5B and C). In Nrdc−/− mice, the number and burden of 
gastric tumors was dramatically reduced compared with that in Nrdc+/+ mice (Fig. 5B,D and E). Thus, deletion of 
Nrdc attenuates gastric tumorigenesis induced by MNU.
Discussion
In the present study, we demonstrated that Nrdc crucially regulates gastric inflammation caused by Helicobacter 
felis infection or forced expression of PGE2. Metaplastic changes following gastric inflammation were suppressed 
by the deletion of Nrdc. The deletion of Nrdc significantly suppressed chemically-induced tumorigenesis of the 
stomach.
Helicobacter pylori-induced gastritis is a primary inflammatory disorder of the human stomach, affecting 
about half of the global population1. Recent improvements in the hygienic environment have reduced the rate 
of Helicobacter pylori infection; however, other causative factors such as non-steroidal anti-inflammatory drugs 
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Figure 2. Stomachs of Nrdc+/+ and Nrdc−/− mice infected with Helicobacter felis. (A) Representative 
macroscopic views of the stomachs of Nrdc+/+ and Nrdc−/− mice infected with Helicobacter felis. (B) Detection 
of Helicobacter felis in the mucosae of Nrdc+/+ and Nrdc−/− mice. Note that Helicobacter felis is detected in 
gastric glands of both Nrdc+/+ and Nrdc−/− mice. Bars = 100 μm. (C) Mucosal thickness of Nrdc+/+ and Nrdc−/− 
mice with or without Helicobacter felis infection. (D) Formation of lymphoid follicle (arrowheads) in Nrdc+/+ 
and Nrdc−/− mouse gastric mucosae. Bars = 100 μm. (E) Inflammation scores of Nrdc+/+ and Nrdc−/− mouse 
gastric mucosae. *P < 0.05. (F) Immunohistochemistry for Gr1 and F4/80 in Nrdc+/+ and Nrdc−/− mice. 
Bars = 100 μm. (G) Number of epithelial cells immunostained for Gr1 and F4/80 in Nrdc+/+ and Nrdc−/− mice. 
*P < 0.05. (H) mRNA expression of Cxcl1 and Ccl2 in the gastric mucosae of Nrdc+/+ and Nrdc−/− mouse 
stomachs. (I) mRNA expression of IL-1α, IL-1β, IL-6, and IL-12 in the gastric mucosae of Nrdc+/+ and Nrdc−/− 
mouse stomachs. *P < 0.05.
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or autoimmunity also contribute to the development of acute and chronic gastritis22. Regardless of the causative 
factors, chronic inflammation of the gastric mucosa can slowly progress to mucosal atrophy, induce metaplastic 
changes, and finally cause gastric cancer. In addition to the treatment of acute gastritis that may result in hem-
orrhagic complications, detection and therapeutic intervention in the early stages of the developmental cascade 
from chronic gastritis to gastric cancer is important. Therefore, it would be helpful to understand the molecular 
basis of chronic inflammation in the stomach.
Chronic inflammation is regulated by a feedback loop consisting of diverse inflammatory cytokines, and is 
closely associated with the recruitment of inflammatory cells in tissues. We previously demonstrated that the 
deletion of Nrdc critically suppresses ectodomain shedding, activation of TNF-α, and the production of other 
inflammatory cytokines in gastric cancer cells14. We also showed that the deletion of Nrdc significantly suppresses 
mouse steatohepatitis with attenuated inflammatory cytokine production and reduced infiltration of inflamma-
tory cells23. Therefore, in this study, we examined the undetermined in vivo role of Nrdc during the developmental 
process of chronic gastritis, metaplastic changes, and gastric tumors.
Figure 3. Gastritis caused by forced expression of prostaglandin E2. (A) Representative macroscopic 
views of the stomachs of Nrdc+/+ and Nrdc−/− mice with forced expression of PGE2 by the insertion of K19-
C2mE alleles. (B) H&E staining of Nrdc+/+ and Nrdc−/− mouse stomachs with forced expression of PGE2. 
Bars = 1000 μm. (C) Mucosal thickness of the Nrdc+/+ and Nrdc−/− mice with forced PGE2 expression. *P < 0.05. 
(D) Immunohistochemistry for Gr1 and F4/80 in Nrdc+/+ and Nrdc−/− mice. Bars = 100 μm. (E) Numbers of 
epithelial cells immunostained for Gr1 and F4/80 in Nrdc+/+ and Nrdc−/− mice. *P < 0.05. (F) mRNA expression 
of Cxcl1 and IL-1β in the gastric mucosae of Nrdc+/+ and Nrdc−/− mouse stomachs. *P < 0.05.
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To mimic chronic infection and inflammation in the human stomach caused by Helicobacter pylori, we used a 
Helicobacter felis-infected mouse model. Mucosae of the gastric corpus were thinner in Nrdc−/− than in Nrdc+/+ 
mice, and the inflammation score was less severe in Nrdc−/− mice. Infiltration of neutrophils and macrophages 
was decreased in Nrdc−/− mice concomitantly with attenuated expression of inflammatory cytokines. Although 
infiltration of inflammatory cells such as neutrophils may not be critical for the development of Helicobacter 
felis-induced gastritis24, this pattern of cytokine expression is consistent with our previous data obtained from a 
human gastric cancer cell line14. Notably, levels of IL-1α, IL-1β, IL-6, and IL-12, which are the main contributors 
to human chronic gastritis, were decreased in Nrdc−/− mice. Thus, the deletion of Nrdc attenuates gastric inflam-
mation, indicating that Nrdc also plays a role in the intravital stomach. It is also important that the deletion of 
Nrdc attenuated inflammation caused by the forced expression of PGE2. This indicated that the deletion of Nrdc 
attenuates gastric inflammation regardless of the cause of inflammation, and a global therapeutic approach may 
be possible by targeting Nrdc.
We next questioned whether Nrdc plays a role in metaplastic changes and tumorigenesis. In Helicobacter 
felis-infected mice, metaplastic changes develop in the gastric corpus, and progress to mucous metaplasia that can 
be stained with Alcian blue25,26. In the present study, metaplastic changes induced by Helicobacter felis infection, 
or forced expression of PGE2, were significantly attenuated by the deletion of Nrdc. More importantly, gastric 
Figure 4. Metaplastic changes in Nrdc+/+ and Nrdc−/− mouse stomachs. (A)Immunohistochemistry for 
TFF2 in Nrdc+/+ and Nrdc−/− mouse stomachs with Helicobacter felis infection. Bars = 100 μm. (B) Areas stained 
for TFF2 in Nrdc+/+ and Nrdc−/− mouse stomachs with Helicobacter felis infection. *P < 0.05. (C) Alcian blue 
staining of Nrdc+/+ and Nrdc−/− mouse stomachs with Helicobacter felis infection. Bars = 100 μm. (D) Areas 
stained with Alcian blue in Nrdc+/+ and Nrdc−/− mouse stomachs with Helicobacter felis infection. *P < 0.05.  
(E) Alcian blue staining of Nrdc+/+ and Nrdc−/− mouse stomachs with PGE2 expression. Bars = 1000 μm. (D) 
Areas stained with Alcian blue in Nrdc+/+ and Nrdc−/− mouse stomachs with forced PGE2 expression. *P < 0.05.
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tumor formation was remarkably suppressed by the same genetic change. It is now becoming clear that the 
tumor microenvironment, which is orchestrated by inflammatory cells, is an indispensable participant during a 
wide-range of tumor developmental processes27.
Inflammation plays decisive roles at different stages of tumor development, including initiation, promotion, 
malignant conversion, invasion, and metastasis28. We previously reported that NRDC is highly expressed in the 
epithelium of human gastric cancer tissues14. Knockdown of NRDC attenuates gastric cancer cell growth both 
in vitro and in a xenograft model. These previous data showed that TNF-α secreted from gastric cancer cells 
themselves initiates a feedback loop to enhance inflammatory cytokine expression.
As for the pivotal role of Nrdc in vivo, we previously showed in a mouse steatohepatitis model that the produc-
tion of inflammatory cytokines and recruitment of inflammatory cells are significantly suppressed concomitantly 
with the suppression of TNF-α release by the deletion of Nrdc23. Although we did not again examined the shed-
ding status of TNF-α in mouse stomach in the present study, the remarkable suppressive effect of Nrdc deletion 
on inflammation may lead to the suppression of metaplastic changes and tumor formation. In this respect, it is 
worth noting that metaplastic changes were detected in Nrdc−/− mice, albeit milder than in Nrdc+/+ mice, and 
that gastric tumor formation was almost completely blocked in Nrdc−/− mice. This discrepancy indicates a possi-
bility that formation of gastric tumors by MNU treatment requires inflammatory responses, and that metaplastic 
changes may be regulated at least partly by factors other than Nrdc. To determine the exact mechanisms underly-
ing how Nrdc coordinates inflammation, metaplastic changes, and tumor formation, further studies are required. 
However, the findings obtained in available studies, including the current work, suggest that a global therapeutic 
approach against various gastric disorders may be possible by targeting NRDC.
Methods
Animal models. Generation of the Nrdc knockout mouse with a CBA background was described previ-
ously15. Animals were housed under specific pathogen-free conditions at the Animal Facilities of Kyoto University. 
All animal experiments were performed in accordance with institutional guidelines. The Review Board of 
Kyoto University granted ethical permission for this study, and The Kyoto University Animal Experimentation 
Committee approved the experimental protocol. For the infection by Helicobacter felis, suspending water contain-
ing Helicobacter felis was gavaged to Nrdc+/+ and Nrdc−/− mice for three days according to the previous report16. 
K19-C2mE mice were generated as previously described16. To analyze chemically-induced gastric tumorigenesis, 
mice at the age of 6 weeks were administered MNU (Sigma-Aldrich, St. Louis, MO, USA) in drinking water at 
240 ppm on alternate weeks for five weeks as described previously19.
Histological and immunohistochemical analyses. Mouse stomach was resected, fixed in 4% buffered 
paraformaldehyde solution, embedded in paraffin, and cut into sections 5-μm thick. For immunostaining, the 
sections were incubated overnight with the primary antibodies at 4 °C, after which the secondary antibodies were 
added. The primary antibodies used were rat anti-F4/80 (Abcam, Cambridge, MA, USA), rat anti–Gr-1 (eBio-
science, San Diego, CA, USA), sheep anti-pepsinogen II (Abcam), mouse anti-H+/K+-ATPase α subunit (MBL, 
Figure 5. Formation of gastric tumors in Nrdc+/+ and Nrdc−/− mouse stomachs. (A) Ki67 immunostaining 
in Nrdc+/+ and Nrdc−/− mouse stomachs with the forced PGE2 expression. Bars = 50 μm. (B) Macroscopic views 
of the stomachs of Nrdc+/+ and Nrdc−/− mice treated with N-methyl-N-nitrosourea (MNU). (C) H&E staining 
of gastric tumor in Nrdc+/+ mouse. Bars = 200 μm (left) and 20 μm (right). (D) Polyp number in the stomachs of 
Nrdc+/+ and Nrdc−/− mice treated with MNU. *P < 0.05. (E) Polyp volume of Nrdc+/+ and Nrdc−/− mouse gastric 
tumors established by MNU treatment. *P < 0.05.
www.nature.com/scientificreports/
8Scientific RepoRts | 7:43052 | DOI: 10.1038/srep43052
Nagoya, Japan), mouse anti-Muc5AC (Abcam), mouse-anti-spasmolytic polypeptide (TFF2) (R&D Systems, 
Minneapolis, MN, USA), and rat anti-Ki67 (Dako, Glostrup, Denmark). All immunohistochemical analyses were 
performed with immunoglobulin isotype controls. For Alcian blue staining, deparaffinized sections were incu-
bated with Alcian blue solution for 30 minutes, followed by counterstaining with Nuclear Fast Red. To determine 
the differentiation status of the gastric mucosa under physiological conditions, stained cells were counted in 10 
randomly selected gastric glands per mouse in 6 Nrdc+/+ and 4 Nrdc−/− mice. In Helicbacter felis infection exper-
iments, we used 12 Nrdc+/+ and 6 Nrdc−/− mice. In addition, 6 Nrdc+/+; K19-C2mE and 3 Nrdc−/−; K19-C2mE 
mouse samples were subjected to the analyses. Using these mice, to analyze histology and count inflammatory 
cells, eight high power field sections from each mouse were selected randomly. To investigate gastric tumorigen-
esis, 12 Nrdc+/+ and 6 Nrdc−/− mice were treated with MNU. Inflammation scores were determined according to 
the previous report24.
Real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Total 
RNA was extracted using Trizol (Life Technologies, Carlsbad, CA, USA). Single-strand complemen-
tary DNA was synthesized using a First Strand SYBR Green Master Mix (Roche Applied Science, 
Basel, Switzerland). qRT-PCR was performed using FastStart SYBR Green Master (Roche Applied 
Science) and the LightCycler 480 system (Roche Applied Science). Values are expressed as arbi-
trary units relative to the expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expres-
sion. The primer sets used were: interleukin (IL)-1α-forward, CTGATGAAGCTCGTCAGGCAG; 
IL-1α-reverse, TGGTGCTGAGATAGTGTTTGTC; IL-1β-forward, GCAACTGTTCCTGAACTCAACT; 
IL-1β-reverse, ATCTTTTGGGGTCCGTCAACT; IL-6-forward, TAGTCCTTCCTACCCCAATTTCC; 
IL6-reverse, TTGGTCCTTAGCCACTCCTTC; IL-12-forward, ACTCTGCGCCAGAAACCTC; 
IL-12-reverse, CACCCTGTTGATGGTCACGAC; Cxcl1-forward, CTGGGATTCACCTCAAGAACATC; 
Cxcl1-reverse, CAGGGTCAAGGCAAGCCTC; Ccl2-forward, ATCCACGGCATACTATCAACATC; 
Ccl2-reverse, CAAGGCTCACCATCATCGTAG; Gapdh-forward, AGGTCGGTGTGAACGGATTTG; 
a n d  G a p d h - r e v e r s e ,  T G TA G A C C AT G TA G T T G A G G T C A .  I n  e a c h  e x p e r i m e n t , 
3–6 samples were subjected to the reactions.
Statistical analyses. Results are expressed as means ± standard error unless stated otherwise. Differences 
between treatments, groups, and strains were analyzed by the two-tailed Student’s t-test.
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